Jason M. Leibowitz

Papers

Total Citations

H-Index

About

Jason M. Leibowitz is a prominent surgical oncologist whose research centers on advancing minimally invasive techniques for head and neck cancers, particularly oropharyngeal carcinoma. His major contributions lie in comparing and refining transoral surgical modalities, including transoral robotic surgery (TORS), transoral laser surgery (TLS), and conventional direct transoral oropharyngectomy. In his highly cited 2019 meta-analysis (32 citations), Leibowitz systematically evaluated outcomes across these approaches, providing critical evidence to guide surgical decision-making and highlighting the comparative efficacy and safety of TORS. His earlier 2013 work on TORS (9 citations) helped establish foundational knowledge on this innovative robotic platform, which reduces morbidity while maintaining oncologic outcomes. Through these studies, Leibowitz has shaped contemporary surgical practice, offering patients less invasive options with faster recovery. His research is widely referenced by surgeons and trainees seeking to optimize treatment for oropharyngeal cancer, underscoring his role as a key voice in the evolution of transoral surgery.